Bicycle Therapeutics plcBCYCNASDAQ
Loading
Revenue Growth AcceleratingAccelerating
Percentile Rank90
5Y CAGR+15.9%
Year-over-Year Change
Year-over-year revenue growth rate
5Y CAGR
+15.9%/yr
Long-term compound
Percentile
P90
Near historical high
vs 5Y Ago
2.1x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | 301.85% |
| Q2 2025 | -70.73% |
| Q1 2025 | 169.07% |
| Q4 2024 | 38.57% |
| Q3 2024 | -71.41% |
| Q2 2024 | -52.07% |
| Q1 2024 | 266.35% |
| Q4 2023 | -0.39% |
| Q3 2023 | -53.04% |
| Q2 2023 | 132.78% |
| Q1 2023 | 53.72% |
| Q4 2022 | 4.77% |
| Q3 2022 | -30.56% |
| Q2 2022 | 13.42% |
| Q1 2022 | 2.36% |
| Q4 2021 | -12.97% |
| Q3 2021 | 142.75% |
| Q2 2021 | -1.27% |
| Q1 2021 | -53.01% |
| Q4 2020 | 0.16% |
| Q3 2020 | 144.56% |
| Q2 2020 | 39.15% |
| Q1 2020 | -78.62% |
| Q4 2019 | 760.10% |
| Q3 2019 | -59.66% |
| Q2 2019 | -76.16% |
| Q1 2019 | 503.97% |
| Q4 2018 | -34.35% |
| Q3 2018 | -3.07% |
| Q2 2018 | -40.85% |
| Q1 2018 | 328.70% |
| Q4 2017 | 0.00% |